Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Major Food Ingredients Firm Chr. Hansen Installs Fill-It™

Published: Friday, October 25, 2013
Last Updated: Friday, October 25, 2013
Bookmark and Share
To meet increasing demand for its high quality bacterial starter cultures.

TAP Biosystems has announced that its Fill-It™; automated benchtop vial filling system has been installed at Chr. Hansen, a global bioscience company that develops natural ingredients for the food and nutritional industries.

The system, which is being utilized for the first time in the food industry, will be used to improve processing throughput of large batches of vials containing bacterial starter cultures for use in variety of fermented food products.

Scientists at Chr. Hansen have factory tested and installed the Fill-It to decrease production time of their culture inoculation material. It will also be used to convert non-Kosher strains to ones that are Kosher certified.

Each vial contains 4mL of a yeast extract media or a thick milk based culture containing up to 100,000 cells/mL of bacterial strains, including Lactobacillus, Lactococcus and Bifidobacterium.

These starter cultures will be distributed globally to Chr. Hansen’s production sites to be used as the first step in producing cultures for yoghurts, fermented milks and cheese, or for wine fermentation.

Microbiologists at Chr. Hansen selected Fill-It for this application because it has the capability to double batch production and more importantly, maintain high quality, contamination-free cultures.

James Lemanczyk, Microbial Service Technician at Chr. Hansen explained: “We were using a huge semi-automated filling system which took two people to operate with one technician loading vials at one end and another one to remove and package the vials at the other. It was very time consuming and we knew we had to upgrade our process to make it not only more efficient but also more consistent. We assessed two automated filling systems but chose Fill-It because the system is so compact we can use it in a standard laminar flow cabinet, we can also fit the system with a disposable tube set, as well as adapt it to fit 5mL sterile Nunc tubes. These features will not only save time with batch set-up but will help us ensure there is minimal operator interaction to produce cultures that are kept pure and contamination free during each run.”

Lemanczyk added: “We also liked the fact that TAP’s staff were willing to work with us in partnership to re-calibrate the Fill-It system to precisely dispense milk cultures. These are challenging as they can be gaseous and are very thick due to the cells lactic acid production which thickens the milk and their bacterial slime production. Now we can fill accurately, we’re really looking forward to implementing the Fill-It system into our new dispensing process.”

Stephen Guy, Fill-It Product Manager at TAP Biosystems commented: “Use of the Fill-It system for its time saving and quality benefits is well established in many international cell banks and we’re delighted that our first installation in the food industry is at such a prestigious nutritional ingredients company. Chr. Hansen’s adoption of our state-of-the-art automation indicates to food ingredients firms looking to improve batch productivity and product consistency that adding a Fill-It system in their workflow is a forward thinking investment.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck and TAP Biosystems Finalists for “Best Collaboration Award”
Recognizing ambr250 as a breakthrough technology for process development.
Wednesday, October 08, 2014
TAP and Gallus Co-host Free Webinar
Explaining the benefits of using ambr15 microbioreactors for DoE.
Wednesday, October 01, 2014
New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors
Detailing how to achieve consistent feeding regimes for reproducible scale-up.
Thursday, September 25, 2014
New Webinar on Mimicking Perfusion Culture Using Micro Bioreactors
Presents validation data for improving media screening and process optimization.
Friday, February 14, 2014
Scientific News
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
Paper Filter Can Remove Viruses from Water
A new paper filter can purify water from viruses, even the most difficult and contagious.
Large-scale HIV Vaccine Trial to Launch in South Africa
NIH-funded study will test safety, efficacy of vaccine regimen.
New HIV Vaccine Target Discovered
NIH-Led team have discovered a new vaccine target site on HIV.
Mimicking Evolution to Create Novel Proteins
A study by researchers in the Kuhlman lab offers a new route to design the 'cellular machines' needed to understand and battle diseases.
Antibody Therapy Opens Door to Potential New Treatment for HIV
Researchers at Rockefeller University show how a broadly neutralizing antibody could be used to help fight HIV.
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!